Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension-a meta-regression analysis of 98 observational studies

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Lin, Chin ^a   Yang, Hsin Yi ^a   Wu, Chia Chao ^b   Lee, Herng Sheng ^b   Lin, Yuh Feng ^b,c   Lu, Kuo Cheng ^d   Chu, Chi Ming ^a   Lin, Fu Huang ^a   Kao, Sen Yeong ^a   Su, Sui Lung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ETHNICITY; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HIGH RISK BEHAVIOR; HUMAN; HYPERTENSION; MALE; META ANALYSIS (TOPIC); MULTIPLE REGRESSION; OBSERVATIONAL STUDY; RARE DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; SYSTEMATIC REVIEW;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; HYPERTENSION; INDEL MUTATION; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS;

EID: 84899550273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087604     Document Type: Article

References (128)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047. (Pubitemid 350074801)
2. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, et al. (2009) Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 13: 621-630.
3. Zhang L, Wang F, Wang L, Wang W, Liu B, et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379: 815-822.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
5. Li S, McAlpine DD, Liu J, Li S, Collins AJ (2004) Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther 11: 5-13. (Pubitemid 38174670)
6. Tsai JC, Chen SC, Hwang SJ, Chang JM, Lin MY, et al. (2010) Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients. Am J Kidney Dis 55: 856-866.
7. McClellan WM, Warnock DG, Judd S, Muntner P, Patzer RE, et al. (2012) Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD. Am J Kidney Dis 59: 25-31.
8. Remuzzi G, Perico N, Macia M, Ruggenenti P (2005) The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl: S57-65.
9. Mizuiri S, Hemmi H, Kumanomidou H, Iwamoto M, Miyagi M, et al. (2001) Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int 60: 1124-1130. (Pubitemid 34205813)
10. Qin YH, Zhou TB, Su LN, Lei FY, Huang WF, et al. (2011) Association between ACE polymorphism and risk of IgA nephropathy: a meta-analysis. J Renin Angiotensin Aldosterone Syst 12: 215-223.
11. Wang F, Fang Q, Yu N, Zhao D, Zhang Y, et al. (2012) Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects. J Renin Angiotensin Aldosterone Syst 13: 161-174.
12. Zhou TB, Yin SS, Qin YH (2012) Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease susceptibility. J Renin Angiotensin Aldosterone Syst [Epub ahead of print].
13. Zhang YF, Cheng Q, Tang NL, Chu TT, Tomlinson B, et al. (2013) Gender difference of serum angiotensin-converting enzyme (ACE) activity in DD genotype of ACE insertion/deletion polymorphism in elderly Chinese. J Renin Angiotensin Aldosterone Syst.
14. Mansoor Q, Bilal N, Qureshi S, Qureshi O, Javaid A, et al. (2010) Gender based disparities in ACE I/D polymorphism associated with progression of diabetic nephropathy in Pakistani patients with type 2 diabetes mellitus. International Journal of Diabetes and Metabolism 18: 67-71.
15. Hadjadj S, Gallois Y, Alhenc-Gelas F, Chatellier G, Marre M, et al. (2003) Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients. Diabet Med 20: 677-682. (Pubitemid 36966565)
16. Palomo-Pinon S, Gutierrez-Rodriguez ME, Diaz-Flores M, Sanchez-Barrera R, Valladares-Salgado A, et al. (2009) DD genotype of angiotensin-converting enzyme in type 2 diabetes mellitus with renal disease in Mexican Mestizos. Nephrology (Carlton) 14: 235-239.
17. Nakajima S, Baba T, Yajima Y (1996) Is ACE gene polymorphism a useful marker for diabetic albuminuria in Japanese NIDDM patients? Diabetes Care 19: 1420-1422. (Pubitemid 26418626)
18. Park HC, Choi SR, Kim BS, Lee TH, Kang BS, et al. (2005) Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Yonsei Med J 46: 779-787. (Pubitemid 43085180)
19. Tomino Y, Makita Y, Shike T, Gohda T, Haneda M, et al. (1999) Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 82: 139-144. (Pubitemid 29263973)
20. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, et al. (2011) The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst 12: 624-633.
21. Zhou TB, Yin SS, Liang R (2012) A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. J Renin Angiotensin Aldosterone Syst [Epub ahead of print].
22. Yu ZY, Chen LS, Zhang LC, Zhou TB (2012) Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy. Nephrology (Carlton) 17: 480-487.
23. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. (2002) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized-studies in meta-analysis. Available: www.ohri.ca/programs/clinical-epidemiology/oxford. asp. Accessed 2013 Aug 23.
24. Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36: 1-48.
25. Schwarzer G (2012) meta: Meta-Analysis with R.
26. Lee YJ, Tsai JC (2002) ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25: 1002-1008.
27. Shaikh R, Shahid SM, Nawab SN, Mansoor Q, Javaid A, et al. (2012) Distribution of ACE I/D polymorphism in the patients of diabetes and nephropathy in Pakistan. Int J Hum Genet 12: 133-138.
28. Rahimi Z, Vaisi-Raygani A, Rahimi Z, Parsian A (2012) Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran. Nephrology 17: 175-181.
29. El-Baz R, Settin A, Ismaeel A, Khaleel AA, Abbas T, et al. (2012) MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 13: 472-477.
30. Zsom M, Fulop T, Zsom L, Barath A, Maroti Z, et al. (2011) Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients. Hemodial Int 15: 501-508.
31. Al-Harbi EM, Farid EM, Gumaa KA, Masuadi EM, Singh J (2011) Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population. Mol Cell Biochem 350: 119-125.
32. Jung ES, Kim SM, Cha RH, Oh YK, Kim YS, et al. (2011) Impact of polymorphisms of the genes encoding angiotensin II-forming enzymes on the progression of IgA nephropathy. Nephron Clin Pract 118: c122-129.
33. Ali A, Vasudevan R, Ismail P, Thiam Seong CL, Chakravarthi S (2011) Analysis of insertion/deletion polymorphisms of the angiotensin converting enzyme gene in Malaysian end-stage renal disease patients. J Renin Angiotensin Aldosterone Syst [Epub ahead of print].
34. Huang HD, Lin FJ, Li XJ, Wang LR, Jiang GR (2010) Genetic polymorphisms of the renin-angiotensin-aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy. Chin Med J (Engl) 123: 3238-3242.
35. Jayapalan JJ, Muniandy S, Chan SP (2010) Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects. Indian J Hum Genet 16: 78-86.
36. Naresh VV, Reddy AL, Sivaramakrishna G, Sharma PV, Vardhan RV, et al. (2009) Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy. Indian J Nephrol 19: 145-148.
37. Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, et al. (2009) Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Diabetes Metab Res Rev 25: 717-724.
38. Nikzamir A, Esteghamati A, Feghhi M, Nakhjavani M, Rashidi A, et al. (2009) The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes. J Renin Angiotensin Aldosterone Syst 10: 109-114.
39. Anbazhagan K, Sampathkumar K, Ramakrishnan M, Gomathi P, Gomathi S, et al. (2009) Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients. Clin Chim Acta 406: 108-112.
40. Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, et al. (2009) ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol 28: 141-150.
41. Mollsten A, Kockum I, Svensson M, Rudberg S, Ugarph-Morawski A, et al. (2008) The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk. J Diabetes Complications 22: 377-383.
42. Eroglu Z, Cetinkalp S, Erdogan M, Kosova B, Karadeniz M, et al. (2008) Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy. J Diabetes Complications 22: 186-190. (Pubitemid 351539058)
43. Arfa I, Abid A, Nouira S, Elloumi-Zghal H, Malouche D, et al. (2008) Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 9: 32-36. (Pubitemid 351546632)
44. Tripathi G, Sharma RK, Baburaj VP, Sankhwar SN, Jafar T, et al. (2008) Genetic risk factors for renal failure among north Indian ESRD patients. Clin Biochem 41: 525-531.
45. Movva S, Alluri RV, Komandur S, Vattam K, Eppa K, et al. (2007) Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J Diabetes Complications 21: 237-241. (Pubitemid 47002317)
46. Uddin M, Azam M, Chowdhury N, Akhteruzzaman S (2007) Angiotensin I-converting enzyme gene polymorphism in type 2 diabetic patients with nephropathy. J Med Sci 7: 682-685. (Pubitemid 46971022)
47. Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D, et al. (2006) Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant 21: 979-983.
48. So WY, Ma RC, Ozaki R, Tong PC, Ng MC, et al. (2006) Angiotensin- converting enzyme (ACE) inhibition in type 2, diabetic patients- interaction with ACE insertion/deletion polymorphism. Kidney Int 69: 1438-1443.
49. Shestakova MV, Vikulova OK, Gorashko NM, Voronko OE, Babunova NB, et al. (2006) The relationship between genetic and haemodynamic factors in diabetic nephropathy (DN): Case-control study in type 1 diabetes mellitus (T1DM). Diabetes Res Clin Pract 74: S41-S50. (Pubitemid 44485245)
50. Ng DP, Placha G, Choo S, Chia KS, Warram JH, et al. (2006) A disease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus. Diabetes 55: 2660-2663. (Pubitemid 44871171)
51. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, et al. (2006) Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet 7: 42.
52. Degirmenci I, Kebapci N, Basaran A, Efe B, Gunes HV, et al. (2005) Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Int J Clin Pract 59: 1137-1142. (Pubitemid 43904518)
53. van der Sman-de Beer F, Verhagen C, Rombach SM, Boorsma P, van Manen JG, et al. (2005) ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis. Kidney Int 68: 2237-2243. (Pubitemid 43117799)
54. Canani LH, Costa LA, Crispim D, Goncalves Dos Santos K, Roisenberg I, et al. (2005) The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes. Diabet Med 22: 1167-1172. (Pubitemid 41224175)
55. Fabris B, Bortoletto M, Candido R, Barbone F, Cattin MR, et al. (2005) Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension. J Hypertens 23: 309-316. (Pubitemid 40279634)
56. Lau YK, Woo KT, Choong HL, Zhao Y, Tan HB, et al. (2004) Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore. Nephron Physiol 97: p1-8.
57. Suzuki H, Sakuma Y, Kanesaki Y, Eiro M, Asahi K, et al. (2004) Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of IgA nephropathy. Clin Nephrol 62: 173-179. (Pubitemid 39236620)
58. Stratta P, Bermond F, Guarrera S, Canavese C, Carturan S, et al. (2004) Interaction between gene polymorphisms of nitric oxide synthase and renin-angiotensin system in the progression of membranous glomerulonephritis. Nephrol Dial Transplant 19: 587-595. (Pubitemid 38263117)
59. Lochynska K, Ciechanowicz A, Pawlaczyk K, Oko A, Czekalski S (2003) Angiotensin-converting enzyme gene insertion/deletion polymorphism in newly diagnosed primary chronic glomerulonephritis. Adv Clin Exp Med 12: 161-165. (Pubitemid 36512038)
60. Papp F, Friedman AL, Bereczki C, Haszon I, Kiss E, et al. (2003) Renin-angiotensin gene polymorphism in children with uremia and essential hypertension. Pediatr Nephrol 18: 150-154. (Pubitemid 41490303)
61. Aucella F, Margaglione M, Vigilante M, Gatta G, Grandone E, et al. (2003) PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant 18: 1142-1146. (Pubitemid 36722516)
62. Okuno S, Utsugi T, Ohno T, Ohyama Y, Uchiyama T, et al. (2003) Angiotensin-converting enzyme gene polymorphism as a potent risk factor for developing microalbuminuria in Japanese patients with type 2 diabetes mellitus: a 9-year follow-up study. J Int Med Res 31: 290-298. (Pubitemid 37038273)
63. Ortiz MA, De Prado A, Donate T, Gallart L, Claramunt H, et al. (2003) Angiotensin-converting enzyme polymorphism gene and evolution of nephropathy to end-stage renal disease. Nephrology (Carlton) 8: 171-176. (Pubitemid 36995086)
64. Wang AY, Chan JC, Wang M, Poon E, Lui SF, et al. (2003) Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 63: 1899-1907. (Pubitemid 36513340)
65. Dixit M, Mansur A, Dixit N, Gilman J, Santarina L, et al. (2002) The role of ACE gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis. J Postgrad Med 48: 266-269; discussion 269.
66. Losito A, Kalidas K, Santoni S, Ceccarelli L, Jeffery S (2002) Polymorphism of renin-angiotensin system genes in dialysis patients-association with cerebrovascular disease. Nephrol Dial Transplant 17: 2184-2188. (Pubitemid 35446676)
67. Yoon HJ, Kim H, Kim HL, Lee SG, Zheng SH, et al. (2002) Interdependent effect of angiotensin-converting enzyme and platelet-activating factor acetylhydrolase gene polymorphisms on the progression of immunoglobulin A nephropathy. Clin Genet 62: 128-134. (Pubitemid 36372712)
68. Fradin S, Goulet-Salmon B, Chantepie M, Grandhomme F, Morello R, et al. (2002) Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab 28: 27-32. (Pubitemid 34168747)
69. Drouet M, Aupetit C, Denizot Y, Bois M, Bridoux F, et al. (2002) Analysis of three genetic markers in IgA nephropathy patients from a single region. Clin Nephrol 57: 253-260. (Pubitemid 34296386)
70. Nicod J, Frey BM, Frey FJ, Ferrari P (2002) Role of the alpha-adducin genotype on renal disease progression. Kidney Int 61: 1270-1275. (Pubitemid 34304487)
71. Araz M, Yilmaz N, Gungor K, Okan V, Kepekci Y, et al. (2001) Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Pract 54: 95-104. (Pubitemid 32964680)
72. Azar ST, Zalloua PA, Medlej R, Halabi G (2001) The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics. Endocr Res 27: 99-108. (Pubitemid 32565581)
73. Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P (2001) Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 60: 46-54. (Pubitemid 32587538)
74. Wang JG, Staessen JA, Tizzoni L, Brand E, Birkenhager WH, et al. (2001) Renal function in relation to three candidate genes. Am J Kidney Dis 38: 1158-1168. (Pubitemid 34193099)
75. Taniwaki H, Ishimura E, Matsumoto N, Emoto M, Inaba M, et al. (2001) Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 24: 1653-1660. (Pubitemid 33716465)
76. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, et al. (2001) Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP 2: 83-87. (Pubitemid 38963875)
77. Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, et al. (2001) Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 12: 541-549. (Pubitemid 32180023)
78. Wu S, Xiang K, Zheng T, Sun D, Weng Q, et al. (2000) Relationship between the renin-angiotensin system genes and diabetic nephropathy in the Chinese. Chin Med J (Engl) 113: 437-441.
79. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, et al. (2000) Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 15: 1008-1013. (Pubitemid 30410373)
80. van Ittersum FJ, de Man AM, Thijssen S, de Knijff P, Slagboom E, et al. (2000) Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 15: 1000-1007. (Pubitemid 30410372)
81. Solini A, Giacchetti G, Sfriso A, Fioretto P, Sardu C, et al. (1999) Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate. Am J Kidney Dis 34: 1002-1009.
82. De Cosmo S, Margaglione M, Tassi V, Garrubba M, Thomas S, et al. (1999) ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes. Diabetes Metab Res Rev 15: 247-253. (Pubitemid 29454473)
83. Miura J, Uchigata Y, Yokoyama H, Omori Y, Iwamoto Y (1999) Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res Clin Pract 45: 41-49. (Pubitemid 29356123)
84. Kuramoto N, Iizuka T, Ito H, Yagui K, Omura M, et al. (1999) Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. Am J Kidney Dis 33: 276-281. (Pubitemid 29072228)
85. Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, et al. (1998) Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years. Nephron 80: 17-24. (Pubitemid 28434687)
86. Walder B, Spanaus KS, Weinreich T, Sawicki PT, Widmer U (1998) Genetic heterogeneity in the renin-angiotensin system and the risk of diabetic nephropathy: Association with the angiotensinogen gene, but not with the ACE gene. J Clin Basic Cardiol 1: 55-58. (Pubitemid 29244287)
87. Freire MB, van Dijk DJ, Erman A, Boner G, Warram JH, et al. (1998) DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus. Nephrol Dial Transplant 13: 2553-2558. (Pubitemid 28445868)
88. Grzeszczak W, Zychma MJ, Lacka B, Zukowska-Szczechowska E (1998) Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. J Am Soc Nephrol 9: 1664-1669.
89. Young RP, Chan JC, Critchley JA, Poon E, Nicholls G, et al. (1998) Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients. Diabetes Care 21: 431-437. (Pubitemid 28101081)
90. Penno G, Chaturvedi N, Talmud PJ, Cotroneo P, Manto A, et al. (1998) Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes 47: 1507-1511. (Pubitemid 28396957)
91. Fernandez-Llama P, Poch E, Oriola J, Botey A, Coll E, et al. (1998) Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int 53: 1743-1747. (Pubitemid 28243759)
92. Frost D, Pfohl M, Clemens P, Haring HU, Beischer W (1998) Evaluation of the insertion/deletion ACE gene polymorphism as a risk factor for carotid artery intima-media thickening and hypertension in young type 1 diabetic patients. Diabetes Care 21: 836-840. (Pubitemid 28487082)
93. Pei Y, Scholey J, Thai K, Suzuki M, Cattran D (1997) Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest 100: 814-820. (Pubitemid 27371699)
94. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, et al. (1997) Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99: 1585-1595. (Pubitemid 27163809)
95. Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, et al. (1997) Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia 40: 327-331. (Pubitemid 27096558)
96. Ringel J, Beige J, Kunz R, Distler A, Sharma AM (1997) Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 40: 193-199. (Pubitemid 27060292)
97. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E (1997) Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 12: 427-429. (Pubitemid 27105613)
98. Kawada N, Moriyama T, Yokoyama K, Yamauchi A, Ando A, et al. (1997) Renin-angiotensin system component gene polymorphisms in Japanese maintenance haemodialysis patients. Nephrology 3: 521-526. (Pubitemid 28109581)
99. Kario K, Kanai N, Nishiuma S, Fujii T, Saito K, et al. (1997) Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb Vasc Biol 17: 252-256. (Pubitemid 27098181)
100. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SL, Gibson SP, et al. (1996) Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 39: 1108-1114. (Pubitemid 26275942)
101. McLaughlin KJ, Harden PN, Ueda S, Boulton-Jones JM, Connell JM, et al. (1996) The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases. Hypertension 28: 912-915. (Pubitemid 26365540)
102. Oh TG, Shin CS, Park KS, Kim SY, Cho BY, et al. (1996) Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients. Korean J Intern Med 11: 133-137.
103. Schmidt A, Kiener HP, Barnas U, Arias I, Illievich A, et al. (1996) Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 7: 314-317. (Pubitemid 26092481)
104. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, et al. (1996) Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39: 97-102. (Pubitemid 26031020)
105. Ohno T, Kawazu S, Tomono S (1996) Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 45: 218-222. (Pubitemid 26102620)
106. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, et al. (1995) Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70: 455-459.
107. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M (1995) Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 44: 80-85.
108. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, et al. (1995) Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18: 983-985.
109. Panagiotopoulos S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ, et al. (1995) Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications 9: 272-276.
110. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, et al. (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44: 489-494.
111. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, et al. (1995) No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 26: 727-731.
112. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, et al. (1995) Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96: 2162-2169.
113. Dudley CR, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ (1995) U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48: 1907-1911.
114. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, et al. (1995) Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345: 1540-1542.
115. Doria A, Warram JH, Krolewski AS (1994) Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43: 690-695.
116. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, et al. (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388. (Pubitemid 24064244)
117. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, et al. (1994) Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ 309: 1608-1612.
118. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, et al. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346. (Pubitemid 20370444)
119. Wolf G, Neilson EG (1993) Angiotensin II as a renal growth factor. J Am Soc Nephrol 3: 1531-1540.
120. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J (2001) Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10: 321-329. (Pubitemid 32424019)
121. Kobori H, Nangaku M, Navar LG, Nishiyama A (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287. (Pubitemid 47481436)
122. Ahmed N (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 67: 3-21.
123. Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, et al. (2006) Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J 28: 1085-1090. (Pubitemid 44883841)
124. Reckelhoff JF, Zhang H, Granger JP (1998) Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31: 435-439.
125. Lim YK, Retnam L, Bhagavath B, Sethi SK, bin Ali A, et al. (2002) Gonadal effects on plasma ACE activity in mice. Atherosclerosis 160: 311-316. (Pubitemid 34159323)
126. Ewing JA, Rouse BA (1978) Hirsutism, race and testosterone levels: comparison of East Asians and Euroamericans. Hum Biol 50: 209-215. (Pubitemid 8386382)
127. Setiawan VW, Haiman CA, Stanczyk FZ, Le Marchand L, Henderson BE (2006) Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 15: 1849-1855. (Pubitemid 44664259)
128. Ellis L, Nyborg H (1992) Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 57: 72-75.